On May 16, PhRMA participated in Financial Times’ US Pharma and Biotech Summit. Robby Zirkelbach, PhRMA’s Chief Public Affairs Officer and Head of Strategic Initiatives, joined a panel discussion titled, “The Impact of a Pivotal Presidential Election on the Biopharma Industry.” During the conversation, Zirkelbach discussed the future of health care policy, emphasizing key Inflation Reduction Act and pharmacy benefit manager (PBM) reforms that will better protect patient access.

When:

May 16, 2024, at 4:30 PM ET

Speakers:

• Eric Gascho, Senior Vice President, Policy and Government Affairs, National Health Council
• Terri Stewart, Senior Vice President, Head of Global Healthcare Government and Public Affairs, EMD Serono
• Robby Zirkelbach, Chief Public Affairs Officer and Head of Strategic Initiatives, PhRMA
• Oliver Barnes, US Pharmaceutical and Biotech Correspondent, Financial Times (Moderator)